Clinical Research Associate
CurrentAt Medpace I completed the 6-month PACE (Professionals Achieving CRA Excellence) Program in December of 2022, which included applying my monitoring skills within on-site, remote, and co-monitoring visits with seasoned CRAs. These trials consisted of phase I breast and other solid tumor oncology, phase II NASH, and phase II psychiatry. Independently, I have gained monitoring experience through conducting Site Initiation Visits (SIVs), Routine Monitoring Visits (RMVs), and Close-Out Visits, both on-site and remotely. My assigned studies have included Phase 1a/1b oncology (breast and other solid tumors), phase I pediatric hematology (IDA), and phase III cardiology (ASCVD).